Señales en vivo de SPI.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:36):

Stats
Volumen de hoy	227 455
Volumen promedio	559 147
Capitalización de mercado	1.00B
EPS	£0 ( 2024-02-28 )
Last Dividend	£0.500 ( 2023-05-25 )
Next Dividend	£0 ( N/A )
P/E	35.43
ATR14	£0.161 (0.06%)

Volumen Correlación

Largo: -0.03 (neutral)

Corto: -0.12 (neutral)

Signal:(52.726) Neutral

Spire Healthcare Group Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Spire Healthcare Group Correlación - Moneda/Commodity

-0.68
( moderate negative )

0.17
( neutral )

-0.18
( neutral )

-0.71
( moderate negative )

-0.11
( neutral )

-0.75
( moderate negative )

Spire Healthcare Group Finanzas

Annual	2023
Ingresos:	£1.36B
Beneficio Bruto:	£520.60M (38.31 %)
EPS:	£0.0676

FY	2023
Ingresos:	£1.36B
Beneficio Bruto:	£520.60M (38.31 %)
EPS:	£0.0676

FY	2022
Ingresos:	£1.20B
Beneficio Bruto:	£440.50M (36.75 %)
EPS:	£0.0214

FY	2021
Ingresos:	£1.11B
Beneficio Bruto:	£491.20M (44.40 %)
EPS:	£-0.0240

Financial Reports:

No articles found.

Spire Healthcare Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0.500 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Spire Healthcare Group Dividend Information - Dividend Junior

Dividend Sustainability Score: 8.47 - good (84.72%) | Divividend Growth Potential Score: 4.15 - Stable (17.00%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£1.800	2015-06-04
Last Dividend	£0.500	2023-05-25
Next Dividend	£0	N/A
Payout Date	2023-06-23
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	£21.20	--
Avg. Dividend % Per Year	0.18%	--
Score	2.58	--
Div. Sustainability Score	8.47
Div.Growth Potential Score	4.15
Div. Directional Score	6.31	--

Next Divdend (Est)
(2024-05-09)

£0.0693 Estimate 3.33 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.58

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£3.80	1.64%
2019	£3.80	3.44%
2020	£2.50	1.76%
2021	£0	0.00%
2022	£0	0.00%
2023	£0.500	0.22%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
VANL.L	Dividend Knight	2023-09-28	Annually	8	0.66%
MNP.L	Dividend Knight	2023-07-06	Quarterly	35	0.71%
DFDU.L	Dividend Knight	2023-09-14	Quarterly	2	0.70%
SHED.L	Dividend Knight	2023-06-29	Semi-Annually	9	2.67%
IEM.L	Dividend Knight	2023-08-10	Annually	18	0.53%
BKG.L	Dividend Knight	2023-08-17	Annually	32	1.27%
ZTF.L	Dividend Knight	2023-09-07	Annually	30	1.13%
NWOR.L	Dividend Knight	2023-06-01	Insufficient data to determine frequency	2	0.88%
ENOG.L	Dividend King	2023-09-14	Quarterly	3	3.46%
SSE.L	Dividend King	2023-07-27	Semi-Annually	32	3.65%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0201	1.500	9.60	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0119	1.200	9.60	10.00	[0 - 0.3]
returnOnEquityTTM	0.0372	1.500	-0.698	-1.047	[0.1 - 1]
payoutRatioTTM	0.0733	-1.000	9.27	-9.27	[0 - 1]
currentRatioTTM	0.691	0.800	-1.544	-1.236	[1 - 3]
quickRatioTTM	0.483	0.800	-1.867	-1.493	[0.8 - 2.5]
cashRatioTTM	0.156	1.500	-0.243	-0.365	[0.2 - 2]
debtRatioTTM	0.203	-1.500	6.62	-9.93	[0 - 0.6]
interestCoverageTTM	1.360	1.000	-0.607	-0.607	[3 - 30]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.286	2.00	9.86	10.00	[0 - 20]
debtEquityRatioTTM	0.627	-1.500	7.49	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.383	1.000	6.95	6.95	[0.2 - 0.8]
operatingProfitMarginTTM	0.0931	1.000	-0.138	-0.138	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.431	1.000	8.72	8.72	[0.2 - 2]
assetTurnoverTTM	0.594	0.800	9.37	7.50	[0.5 - 2]
Total Score				8.47

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.29	1.000	6.44	0	[1 - 100]
returnOnEquityTTM	0.0372	2.50	-0.449	-1.047	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.286	2.00	9.90	10.00	[0 - 30]
dividendYielPercentageTTM	0.204	1.500	4.91	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
payoutRatioTTM	0.0733	1.500	9.27	-9.27	[0 - 1]
pegRatioTTM	-38.04	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.147	1.000	8.82	0	[0.1 - 0.5]
Total Score				4.15

Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.